MATTHEW W. FOEHR
@matthewwfoehr4628
Director
Building LIGAND PHARMACEUTICALS INC as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Viking Therapeutics, Inc. was founded in 2012 and has no closure on record.
Named alongside
- CHARLES S. BERKMANDirector
- DAVID M. KNOTTDirector
- JASON S. ARYEHDirector
- JOHN L. HIGGINSExecutive Officer, Director
- JOHN M. LAMATTINADirector
- JOHN S. KOZARICHDirector
- MATTHEW W. KORENBERGDirector
- MELANIE S. HERMANDirector
At OmniAb, Inc.
- Carolyn R. BertozziDirector
- Charles W. BerkmanExecutive Officer
- Jennifer W. CochranDirector
- John W. HigginsDirector
- Kurt W. GustafsonExecutive Officer
- Philip J. GotwalsDirector
- Steve R. CrouseDirector
- Steve R. LoveDirector
At Qualigen Therapeutics, Inc.
- Andrew J. RitterExecutive Officer, Director
- Braeden LichtiDirector
- Campbell BecherDirector
- Cody B. PriceDirector
- Cody PriceDirector
- Graydon BenslerDirector
- Ira E. RitterExecutive Officer, Director
- John W. BeckExecutive Officer
- Brian LianPresident, Chief Executive Officer and Director
- J. Matthew SingletonDirector
- Lawson MacartneyDirector
- Michael MorneauChief Financial Officer
- Stephen W. WebsterDirector
Contribution
MATTHEW's ideas, decisions and failures appear here once this profile is claimed.
Companies
- LIGAND PHARMACEUTICALS INCPharmaceutical Preparations; formerly LIGAND PHARMACEUTICALS; listed on Nasdaq as LGND; filing with the SEC since 2015Director · Pharmaceuticals · LA JOLLA, United States
- Viking Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as VKTX; filing with the SEC since 2014Director · Biotechnology · SAN DIEGO, United States · Founded 2012
- Qualigen Therapeutics, Inc.Finance Services; formerly AIxCrypto Holdings, Inc.; listed on Nasdaq as AIXC; filing with the SEC since 2009Director · Biotechnology · CARLSBAD, United States
- OmniAb, Inc.Services-Commercial Physical & Biological Research; formerly Avista Public Acquisition Corp. II; listed on Nasdaq as OABIW; filing with the SEC since 2021Executive Officer, Director · Biotechnology · EMERYVILLE, United States · Founded 2022